Students accepted on UK degree courses reaches record high
A total of 439,180 applicants have gained a place at university or college – up 3.1% on the same point last year, according to data published by the university admissions service.
Ucas said it is the highest number of placed students on results day on record.
Overall, 82% of UK 18-year-old applicants awaiting a decision on results day secured their first choice – which was the same proportion as last year.
For 18-year-olds in the UK, 255,130 applicants have been accepted onto a university or college course – up 4.7% on last year.
The number of international students who have been accepted on to undergraduate courses has risen by 2.9% – from 51,170 last year to 52,640.
Accepted applicants from China (12,380) are up 13% compared with last year.
Jo Saxton, chief executive of Ucas, said: 'This year's students were just thirteen when the pandemic hit, and their secondary schooling was turned upside down.
'It's great to see these applicants securing a university place in record numbers, seeking more education and investing in their futures.
'I am equally delighted to see how universities across the country have responded to their ambition.
'For any student who didn't quite get the grades they were hoping for, or even those still yet to apply, there are plenty of options in clearing with around 27,000 available courses.
'Ucas experts are also available on the phones, on social media and on the Ucas website, to help all those deciding on the next step that's right for them.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why Novo Nordisk Flew Almost 3% Higher on Friday
Key Points The company's leading product looked more attractive following price hikes by a competitor. Eli Lilly's Zepbound will become more expensive in the U.K. and likely throughout Europe subsequently. 10 stocks we like better than Novo Nordisk › An archrival's pricing move was seen as beneficial for Novo Nordisk (NYSE: NVO) on Friday. As investors disseminated news of a dramatic increase in the cost of a product competing with the company's star drug, Wegovy, they pushed the Danish pharmaceutical company's share price up. It closed the day almost 3% higher during a session when the S&P 500 index ended up slumping by 0.3%. A rival's hikes The previous day, U.S. healthcare giant Eli Lilly announced that it was raising the prices of Zepbound -- a GLP-1 obesity drug that directly competes with Wegovy -- in the U.K. In doing so, the company indicated that it will follow suit in other European markets. The move follows a Trump administration push to reduce drug prices in America (or, at least, effectively level them across the world). In late July, the president sent letters to the CEOs of top U.S. drug companies, stating that they had until Sept. 29 to reduce the costs of certain medications. Failure to do so, the president wrote somewhat vaguely, would see the federal government "deploy every tool in our arsenal to protect American families." Although Novo Nordisk also received one of these letters -- there were 17 in all -- the company hasn't given any concrete indication that it intends to make adjustments similar to Eli Lilly's. Customer rebellion brewing? For the moment, then, Novo Nordisk enjoys a bit of an advantage, as there is inevitably customer backlash (and often defection to rival products) when a company hikes prices. We've yet to see how Trump's initiative will fully play out, however. So, personally, I don't think any investor should base their Novo Nordisk stance on the Eli Lilly development. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Flew Almost 3% Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Budgeting, saving, & investing: 4 things you need to know
John Auten-Schneider and David Auten-Schneider, hosts of Yahoo Finance's Living Not So Fabulously podcast, join Mind Your Money with Allie Canal to answer Yahoo Finance readers' top four questions about budgeting, saving, and investing. To watch more expert insights and analysis on the latest market action, check out more Mind Your Money. Related videos Lloyds becomes UK's first bank to introduce £300 rule from end of this month Trump tariffs trigger US inflation shock This FTSE 100 stock is forecast to beat Rolls-Royce in the coming year — and it's only £1! Down 86% over five years, this FTSE stock could be nearing the bottom Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Kingsmill and Hovis agree £70m merger in competition test for Reeves
Kingsmill and Hovis have agreed to a £70m merger to create Britain's biggest bakery, testing the competition watchdog's resolve after pressure from Rachel Reeves to approve more deals. Associated British Foods (ABF), which owns Kingsmill through its Allied Bakeries division, on Friday said it planned to purchase rival baker Hovis from its private equity owner, Endless. The deal will create the UK's biggest bread company, overtaking the current market leader, Warburton's. It comes as both Hovis and Kingsmill have struggled with profitability amid falling demand for sliced loaves in recent years. ABF's tie-up must be approved by the Competition and Markets Authority (CMA), which is under pressure from the Government to wave through more mergers. Clive Black, of Shore Capital, said: 'If [Ms Reeves] is interested in protecting jobs, then absolutely this is going to be a very good test case, because I severely question the viability of these two businesses in the long run if they don't merge. 'I think it could be quite dangerous, from a practical perspective in terms of jobs and supply chains, if the CMA took a very simplistic view of things, because both businesses are loss-making.' In an unprecedented intervention this year, Marcus Bokkerink, the CMA chairman, was ousted by ministers following warnings from the Chancellor that it needed to rip up red tape to boost growth. He was replaced on an interim basis by Doug Gurr, the former Amazon UK boss, with the intervention widely interpreted as signalling that Britain would be open to approving more takeovers. ABF owns Kingsmill through Allied Bakeries, which was founded in 1935. Hovis has been owned by the private equity firm Endless since 2020. It was formerly owned by Premier Foods, the owner of Mr Kipling. Demand for sliced loaves and traditional bakery products has fallen amid rising worries over excess carbohydrate consumption and concerns around so-called ultra-processed foods (UPF). Soaring costs in the wake of the pandemic have heaped further pressure on bakeries. The price of wheat, which surged due to the Ukraine war, has proved particularly burdensome. Kingsmill and Hovis have faced steep competition from Warburtons in recent years, which has pivoted away from traditional loaves towards other baked goods like crumpets, bagels and flatbreads. George Weston, the chief executive of ABF, said: 'This transaction will create a UK bakeries business that is both profitable and sustainable over the long term.' The CMA declined to comment. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
